Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| 1 |
Philip Morris
PM
|
+$1.08B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$605M |
| 3 |
Microsoft
MSFT
|
+$523M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$397M |
| 5 |
Meta Platforms (Facebook)
META
|
+$367M |
Top Sells
| 1 |
GSK
GSK
|
+$307M |
| 2 |
Financial Select Sector SPDR Fund
XLF
|
+$290M |
| 3 |
Morgan Stanley
MS
|
+$270M |
| 4 |
Merck
MRK
|
+$208M |
| 5 |
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
|
+$178M |
Sector Composition
| 1 | Financials | 21.57% |
| 2 | Technology | 13.85% |
| 3 | Healthcare | 8.36% |
| 4 | Communication Services | 8.34% |
| 5 | Industrials | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Goldman Sachs BDC
GSBD
$1.29B
| $3.82M | ﹤0.01% |
194,760
+50,636
| +35% | +$993K |
|
2152
iHeartMedia
IHRT
$432M
| $3.81M | ﹤0.01% |
141,474
+3,787
| +3% | +$102K |
|
2153
Agree Realty
ADC
$8.06B
| $3.81M | ﹤0.01% |
54,011
+7,354
| +16% | +$518K |
|
2154
Magnite
MGNI
$3.26B
| $3.81M | ﹤0.01% |
112,508
-21,610
| -16% | -$731K |
|
2155
Wyndham Hotels & Resorts
WH
$6.48B
| $3.79M | ﹤0.01% |
52,470
-7,451
| -12% | -$539K |
|
2156
FS KKR Capital
FSK
$4.78B
| $3.79M | ﹤0.01% |
176,208
+128,216
| +267% | +$2.76M |
|
|
IGR
2157
CBRE Global Real Estate Income Fund
IGR
$787M
| $3.79M | ﹤0.01% |
429,893
+68,177
| +19% | +$601K |
|
2158
United Fire Group
UFCS
$807M
| $3.77M | ﹤0.01% |
135,905
+90,945
| +202% | +$2.52M |
|
2159
iShares 1-3 Year International Treasury Bond ETF
IGOV
$1.13B
| $3.76M | ﹤0.01% |
71,852
-37,505
| -34% | -$1.96M |
|
2160
Advanced Drainage Systems
WMS
$11.2B
| $3.75M | ﹤0.01% |
32,159
-834
| -3% | -$97.2K |
|
2161
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.41B
| $3.74M | ﹤0.01% |
41,024
-2,934
| -7% | -$268K |
|
2162
SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.44B
| $3.74M | ﹤0.01% |
48,213
-69,846
| -59% | -$5.42M |
|
|
TSC
2163
DELISTED
TriState Capital Holdings, Inc.
TSC
| $3.73M | ﹤0.01% |
182,959
-55,650
| -23% | -$1.13M |
|
2164
Nuvve Holding Corp
NVVE
$4.88M
| $3.73M | ﹤0.01% |
675
-277
| -29% | -$1.53M |
|
2165
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$405M
| $3.73M | ﹤0.01% |
154,092
+83,681
| +119% | +$2.02M |
|
|
CRF
2166
Cornerstone Total Return Fund
CRF
$1.21B
| $3.71M | ﹤0.01% |
333,716
+34,359
| +11% | +$382K |
|
|
JPS
2167
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
| $3.71M | ﹤0.01% |
372,562
-618
| -0.2% | -$6.16K |
|
2168
iShares MSCI Intl Value Factor ETF
IVLU
$2.64B
| $3.71M | ﹤0.01% |
143,669
+39,970
| +39% | +$1.03M |
|
2169
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.65B
| $3.69M | ﹤0.01% |
52,621
-2,842
| -5% | -$200K |
|
2170
iShares US Telecommunications ETF
IYZ
$604M
| $3.69M | ﹤0.01% |
111,156
-28,996
| -21% | -$963K |
|
2171
Upstart Holdings
UPST
$6.45B
| $3.68M | ﹤0.01% |
29,489
+18,968
| +180% | +$2.37M |
|
2172
Webster Financial
WBS
$9.98B
| $3.67M | ﹤0.01% |
68,720
+11,558
| +20% | +$616K |
|
|
NVRO
2173
DELISTED
NEVRO CORP.
NVRO
| $3.66M | ﹤0.01% |
22,097
+1,333
| +6% | +$221K |
|
2174
Nuveen California Quality Municipal Income Fund
NAC
$1.66B
| $3.66M | ﹤0.01% |
230,810
-138,827
| -38% | -$2.2M |
|
2175
Intellia Therapeutics
NTLA
$1.26B
| $3.65M | ﹤0.01% |
22,563
-1,505
| -6% | -$244K |
|